Epilepsy denotes any of various neurological disorders characterized by sudden recurring attacks of motor, sensory, or psychic malfunction with or without loss of consciousness or convulsive seizures.
U.S. Food and Drug Administration Approved Sabril to Treat Spasms in Infants and Epileptic Seizures. – Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to 2 years.
Medsafe, New Zealand’s Ministry of Health’s medicines regulatory arm, is alerting health care professionals in New Zealand about a small increased risk of suicidal thoughts and behaviours in patients taking anti-epileptic medicines. – Medsafe, New Zealand’s Ministry of Health’s medicines regulatory arm, is alerting health care professionals in New Zealand about a small increased risk of suicidal thoughts and behaviours in patients taking anti-epileptic medicines.
The U.S. Food and Drug Administration today issued new information to health care professionals to alert them about an increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions. – An increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions, reported by U.S. Food and Drug Administration (FDA).
Yale School of Medicine researchers have shown for the first time that it is possible to suppress the development of epilepsy in genetically predisposed animals?which could open the door to treating epilepsy as a preventable disease. – It is possible to suppress the development of epilepsy in genetically predisposed animals revealed by Yale School of Medicine researchers. This new study would open the door to treating epilepsy as a preventable disease.
